Clinical trial
Ranolazine Implantable Cardioverter-Defibrillator Trial
NCT01215253
Study timeline
Study start (unknown)2011-09-01Date precision: month
Registry last updated2018-08-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
RanolazineDRUG · verified · RxNorm: ranolazine
Sponsors & collaborators
University of Rochesterlead sponsor
Mapped research locations
BrooklynNew York, United States3New YorkNew York, United States2PhiladelphiaPennsylvania, United States2BaltimoreMaryland, United States2PittsburghPennsylvania, United States2CincinnatiOhio, United States2PortlandOregon, United States2MontrealQuebec, Canada2DurhamNorth Carolina, United States2HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01215253 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.